JT

John C. Timmer

IB Inhibrx Biosciences: 8 patents #2 of 23Top 9%
RP Regeneron Pharmaceuticals: 1 patents #121 of 345Top 40%
📍 Village of La Jolla, CA: #13 of 352 inventorsTop 4%
🗺 California: #1,257 of 55,090 inventorsTop 3%
Overall (2025): #9,460 of 469,880Top 3%
8
Patents 2025

Issued Patents 2025

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12421315 CLL-1 targeted immunotherapies Jordan Jarjour, Mark Pogson, Wai-Hang Leung, Lucas Rascon, Angelica Sanabria +1 more 2025-09-23
12365728 DLL3 single domain antibodies and therapeutic compositions thereof Brendan P. Eckelman, Michael D. KAPLAN, Katelyn M. Willis, Rajay Pandit, Angelica Sanabria +2 more 2025-07-22
12331126 OX40-binding polypeptides and uses thereof William Crago, Kyle S. Jones, Katelyn M. Willis, Florian Sulzmaier, Bryan Becklund +1 more 2025-06-17
12331132 Multispecific polypeptide constructs having constrained CD3 binding and related methods and uses Brendan P. Eckelman, Michael D. KAPLAN, Katelyn M. Willis 2025-06-17
12297271 PD-1 single domain antibodies and therapeutic compositions thereof Rajay Pandit, Angelica Sanabria, Florian Sulzmaier, Brendan P. Eckelman 2025-05-13
12227584 Multivalent and multispecific OX40-binding fusion proteins Brendan P. Eckelman, Chelsie Macedo, Kyle S. Jones, Abrahim Hussain, Amir S. Razai +5 more 2025-02-18
12195533 Multispecific polypeptide constructs containing a constrained CD3 binding domain and a receptor binding region and methods of using the same Brendan P. Eckelman, Michael D. KAPLAN, Katelyn M. Willis, Quinn Deveraux, Kyle S. Jones +1 more 2025-01-14
12187804 Multivalent and multispecific 41BB-binding proteins Brendan P. Eckelman, Chelsie Macedo, Kyle S. Jones, Abrahim Hussain, Amir S. Razai +5 more 2025-01-07